Proceedings of the 2nd Lawang Sewu International Symposium on Health Sciences: Medical Laboratory Technology (LSISHS-MLT 2023)

The Relationship Between Glycemic Control and Length of Treatment in Tuberculosis Patients with Diabetes Mellitus

Authors
Ika Dyah Kurniati1, *, Prihatin Iman Nugroho1, Jalu Panjongko1, Raihan Diki Ramadhanela1
1Universitas Muhammadiyah Semarang, Semarang, Central Java, 50273, Indonesia
*Corresponding author. Email: ika@unimus.ac.id
Corresponding Author
Ika Dyah Kurniati
Available Online 22 July 2024.
DOI
10.2991/978-94-6463-457-0_12How to use a DOI?
Keywords
Glycemic Control; HbA1c; Tuberculosis; Diabetes Mellitus
Abstract

Comorbidity between diabetic mellitus (DM) and tuberculosis (TB) can raise the incidence of the other. Uncontrolled diabetes mellitus (plasma HbA1C level > 7.0%) and five additional risk factors were discovered to have an impact on the failure of TB treatment. This study aims to identify the relationship between glycemic control and the length of treatment in patients with tuberculosis and diabetes mellitus. This type of research is analytical observational research with a cross-sectional design. This study used a total sampling, namely where all members of the population were sampled, a total of 31 TB patients with DM from December 2019 technique to August 2023 who met the inclusion criteria. The tools used in this research are medical record data and blood lab results (HbA1c). Bivariate analysis was carried out using the chi square test with significance α = 0.05. The result of this research showed that the majority of TB-DM patient was male as 17 samples (54.8%). Most of the sample aged were > 50 years old as many as 22 samples (71.0%), 26 samples had HbA1c levels ≥ 7%, and the majority TB treatment duration ≤ 6 months were 18 samples (58.06%). The results of the chi-square test show p-value = 0.083 p (>0.05), meaning that there is no significant relationship between glycemic control and the length of treatment for TB-DM patients. The conclusion is glycemic control and treatment duration for TB-DM patients do not significantly correlate.

Copyright
© 2024 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

Volume Title
Proceedings of the 2nd Lawang Sewu International Symposium on Health Sciences: Medical Laboratory Technology (LSISHS-MLT 2023)
Series
Advances in Biological Sciences Research
Publication Date
22 July 2024
ISBN
978-94-6463-457-0
ISSN
2468-5747
DOI
10.2991/978-94-6463-457-0_12How to use a DOI?
Copyright
© 2024 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

TY  - CONF
AU  - Ika Dyah Kurniati
AU  - Prihatin Iman Nugroho
AU  - Jalu Panjongko
AU  - Raihan Diki Ramadhanela
PY  - 2024
DA  - 2024/07/22
TI  - The Relationship Between Glycemic Control and Length of Treatment in Tuberculosis Patients with Diabetes Mellitus
BT  - Proceedings of the 2nd Lawang Sewu International Symposium on Health Sciences: Medical Laboratory Technology (LSISHS-MLT 2023)
PB  - Atlantis Press
SP  - 105
EP  - 111
SN  - 2468-5747
UR  - https://doi.org/10.2991/978-94-6463-457-0_12
DO  - 10.2991/978-94-6463-457-0_12
ID  - Kurniati2024
ER  -